Clinical Trials Directory

Trials / Terminated

TerminatedNCT01368211

Mirasol-Treated Platelets - (Pathogen Reduction Extended Storage Study)

PRESS Pathogen Reduction Extended Storage Study PRESS (Pathogen Reduction Extended Storage Study) A Pilot Study of Mirasol Platelets Treated in Platelet Additive Solution in Thrombocytopenic Patients

Status
Terminated
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
16 (actual)
Sponsor
Terumo BCTbio · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The PRESS trial is a single-center, two-part, randomized cross-over pilot study in Copenhagen that will evaluate 1) the safety and performance of Mirasol-treated and untreated platelet products stored for 2-4 days and for 7-days in Platelet Additive Solution (PAS) and 2) the correlation between the TEG® parameters and platelet count increments after platelet transfusions in thrombocytopenic subjects.

Detailed description

1. To evaluate in thrombocytopenic subjects the efficacy and safety of platelets treated with Mirasol Pathogen Reduction Technology (PRT) in Platelet Additive Solution. The following safety and efficacy measures will be compared between Mirasol treated and untreated platelets stored for 2-4 days and stored for 7 days: * Thrombelastography (TEG®) parameters: reaction time R, alpha angle α and maximal amplitude (MA) * Platelet Count Increment and Corrected Count Increment * Time to next platelet transfusion * Incidence of transfusion related (serious) adverse events * Incidence and severity of bleedings 2. To evaluate the use of the TEG® parameters as a measure for platelet transfusion efficacy and to evaluate the correlation between the TEG® parameters and the platelet Corrected Count Increments after platelet transfusions in thrombocytopenic subjects.

Conditions

Interventions

TypeNameDescription
BIOLOGICAL2-4-day-old Mirasol-treated Platelets Transfusion2-4-day-old Mirasol-treated Platelets Units with: * Platelet yield between 2.4x10e11 and 4.5x10e11 * Plasma carryover of \>32% * Cell count \> 800x103/µL
BIOLOGICAL2-4-day-old Untreated Platelets Transfusion2-4-day-old Untreated Platelets Units with: * Platelet yield between 2.4x10e11 and 4.5x10e11 * Plasma carryover of \>32% * Cell count \> 800x103/µL

Timeline

Start date
2010-09-01
Primary completion
2011-04-01
Completion
2011-05-01
First posted
2011-06-07
Last updated
2016-06-28
Results posted
2014-04-07

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT01368211. Inclusion in this directory is not an endorsement.